background
lung
transplant
recipi
frequent
expos
respiratori
virus
particularli
risk
sever
complic
aim
studi
assess
associ
among
presenc
respiratori
viru
detect
molecular
assay
bronchoalveolar
lavag
bal
fluid
respiratori
symptom
acut
reject
adult
lung
transplant
recipi
method
upper
nasopharyng
swab
lower
bal
respiratori
tract
specimen
lung
transplant
recipi
enrol
cohort
studi
undergo
bronchoscopi
bal
transbronchi
biopsi
screen
use
differ
polymeras
chain
reactionbas
assay
result
bal
fluid
biopsi
specimen
bronchoscop
procedur
perform
patient
analyz
also
compar
pair
nasopharyng
bal
fluid
specimen
collect
subgroup
case
overal
viral
posit
rate
upper
respiratori
tract
specimen
bal
sampl
observ
signific
associ
presenc
respiratori
symptom
posit
viral
p
detect
lower
respiratori
tract
convers
acut
reject
associ
presenc
p
p
viral
infect
odd
ratio
confid
interv
recoveri
lung
function
significantli
slower
acut
reject
viral
infect
present
tempor
relationship
exist
acut
respiratori
symptom
posit
viral
nucleic
acid
detect
bal
fluid
lung
transplant
recipi
provid
evid
suggest
respiratori
virus
associ
acut
graft
reject
acut
phase
infect
lung
transplant
recipi
expos
respiratori
virus
circul
yearround
commun
gener
popul
infect
lead
selflimit
upper
respiratori
tract
diseas
protract
respiratori
viral
infect
lower
respiratori
tract
complic
like
lung
transplant
recipi
relat
specif
risk
factor
includ
direct
exposur
graft
airborn
virus
impair
mucociliari
clearanc
poor
cough
flex
abnorm
lymphat
drainag
nevertheless
knowledg
clinic
effect
respiratori
virus
incomplet
particularli
detect
molecular
assay
appli
lower
respiratori
tract
specimen
part
due
retrospect
design
avail
studi
use
differ
sampl
site
upper
vs
lower
respiratori
tract
specimen
heterogen
diagnost
procedur
convent
vs
molecular
techniqu
addit
direct
consequ
viral
infect
subsequ
cellular
injuri
alter
host
immun
could
also
initi
cascad
immunolog
event
lead
acut
chronic
allograft
reject
although
sever
studi
support
associ
respiratori
virus
chronic
lung
reject
link
respiratori
virus
acut
reject
studi
mainli
small
case
seri
subgroup
analysi
basi
avail
evid
relationship
viral
infect
acut
reject
establish
present
investig
specif
design
assess
epidemiolog
respiratori
virus
bronchoalveolar
lavag
bal
fluid
lung
transplant
recipi
analyz
relationship
virus
presenc
acut
graft
reject
sensit
molecular
assay
method
use
identifi
mani
common
respiratori
virus
lower
also
upper
respiratori
tract
symptom
care
prospect
describ
associ
either
respiratori
virus
acut
reject
analyz
studi
period
novemb
march
cover
winter
season
lung
transplant
recipi
enrol
prospect
cohort
studi
patient
follow
site
singl
transplant
network
includ
univers
hospit
geneva
geneva
switzerland
univers
hospit
lausann
lausann
switzerland
inform
consent
requir
particip
studi
approv
institut
ethic
committe
lung
transplant
recipi
underw
bronchoscopi
bal
transbronchi
biopsi
elig
irrespect
reason
lead
procedur
basi
standard
guidelin
perform
routin
schedul
bronchoscopi
month
transplant
yearli
thereaft
indic
bronchoscopi
transbronchi
biopsi
includ
unexplain
respiratori
symptom
function
deterior
decreas
forc
expiratori
volum
fev
new
chest
radiolog
infiltr
control
procedur
month
treatment
reject
grade
higher
thu
patient
could
undergo
bronchoscopi
varieti
reason
addit
procedur
studi
period
technic
reason
eg
pathologist
avail
transbronchi
biopsi
perform
weekend
holiday
center
safeti
ethic
reason
addit
bronchoscopi
perform
purpos
studi
bal
procedur
realtim
taqman
reversetranscript
polymeras
chain
reaction
rtpcr
assay
detect
rna
respiratori
virus
influenza
virus
b
c
respiratori
syncyti
virus
b
parainfluenza
virus
human
rhinoviru
enteroviru
human
metapneumoviru
coronavirus
perform
describ
elsewher
recent
identifi
bocaviru
ad
transbronchi
biopsi
perform
fluoroscop
guidanc
use
standard
procedur
analyz
accord
publish
guidelin
senior
pathologist
mask
viral
result
pool
nasopharyng
oropharyng
swab
specimen
obtain
patient
agre
procedur
technic
reason
reason
cost
rtpcr
assay
perform
procedur
nasopharyng
oropharyng
swab
limit
case
select
entir
studi
period
swab
immedi
place
appropri
transport
medium
store
rtpcr
analysi
shortli
bronchoscop
procedur
specif
case
report
form
complet
symptom
reason
lead
bal
procedur
presum
diagnosi
base
avail
clinic
data
time
record
rhinopharyng
defin
presenc
acut
respiratori
symptom
least
acut
rhinorrhea
without
addit
sign
suggest
acut
sinus
andor
acut
pharyng
sore
throat
confirm
presenc
inflammatori
sign
clinic
examin
flulik
ill
defin
presenc
temperatur
plu
follow
symptom
cough
myalgia
sore
throat
headach
avail
lung
function
measur
week
time
week
bal
procedur
record
fev
maxim
midexpiratori
flow
also
record
impair
lung
function
defin
decreas
previou
valu
statist
analysi
episod
classifi
categori
accord
respect
absenc
grade
presenc
grade
acut
reject
andor
respiratori
viru
consid
acut
reject
grade
higher
analysi
center
would
recommend
highdos
immunosuppress
treatment
lower
acut
reject
grade
fisher
exact
test
use
compar
frequenc
respiratori
symptom
categori
gener
linear
latent
mix
model
stata
softwar
version
statacorp
use
analysi
lung
function
episod
take
account
repeat
measur
patient
studi
site
odd
ratio
or
acut
reject
associ
respiratori
virus
calcul
use
statist
approach
repeat
measur
investig
potenti
timespecif
relationship
respiratori
virus
acut
reject
repeat
analys
episod
restrict
key
period
month
month
month
month
lung
transplant
seventyseven
lung
transplant
recipi
underw
bronchoscopi
patient
characterist
given
tabl
patient
receiv
induct
immunosuppress
antiinterleukin
receptor
antibodi
basiliximab
postop
follow
tripl
immunosuppress
regimen
calcineurin
target
rapa
bronchoscopi
perform
routin
schedul
procedur
perform
new
clinic
condit
perform
control
biopsi
treatment
acut
reject
grade
higher
episod
patient
includ
routin
schedul
bronchoscopi
present
new
respiratori
symptom
without
function
impair
andor
new
radiolog
infiltr
taken
togeth
case
least
new
respiratori
symptom
new
radiolog
infiltr
basi
pretest
evalu
acut
lung
reject
infect
suspect
physician
charg
mask
microbiolog
result
case
case
respect
remain
case
clinician
suspect
particular
diagnosi
rtpcr
assay
rtpcr
viral
assay
perform
bal
fluid
specimen
reveal
overal
posit
rate
eight
bal
specimen
discard
ben
p
caus
thaw
electr
power
outag
rhinoviru
frequent
encount
viru
follow
coronavirus
parainfluenza
virus
tabl
viral
posit
rate
pool
nasopharyng
oropharyng
specimen
test
total
studi
popul
agreement
upper
n
p
lower
respiratori
tract
specimen
accord
type
viral
genu
shown
figur
although
influenza
virus
human
metapneumoviru
bocaviru
mostli
even
exclus
bocaviru
found
upper
airway
sampl
virus
rhinovirus
respiratori
syncyti
virus
found
equal
upper
lower
respiratori
tract
viru
exclus
found
lower
airway
associ
clinic
suspicion
final
diagnosi
bal
fluid
specimen
collect
varieti
clinic
condit
abl
analyz
associ
among
symptom
diagnosi
suspect
physician
charg
subsequ
presenc
proven
upper
lower
respiratori
tract
viral
infect
found
signific
associ
posit
viral
nucleic
acid
detect
bal
fluid
presenc
least
new
respiratori
symptom
particular
cough
sputum
prop
p
p
p
duction
tabl
give
clinic
find
associ
p
p
viru
posit
upper
lower
tract
specimen
physician
charg
suspect
infect
case
virusposit
bal
fluid
compar
case
viru
neg
histori
rhinopharyng
document
case
virusposit
nasopharyng
swab
specimen
compar
neg
biopsi
specimen
show
evid
acut
reject
reveal
minim
reject
grade
higher
similar
analysi
given
tabl
first
test
accuraci
pretest
clinic
evalu
perform
physician
charg
acut
reject
suspect
clinician
charg
histolog
confirm
case
absenc
respiratori
viru
case
respiratori
viru
simultan
identifi
bal
fluid
tabl
consist
result
shown
tabl
presenc
respiratori
symptom
cough
sputum
significantli
associ
presenc
viral
p
infect
bal
fluid
irrespect
presenc
absenc
acut
reject
impair
lung
function
relat
acut
reject
also
significantli
worsen
presenc
viral
infect
figur
patient
simultan
acut
reject
lower
respiratori
tract
viral
infect
fev
recoveri
rate
significantli
slower
patient
acut
reject
without
simultan
viral
infect
p
found
acut
reject
presenc
viral
infect
period
studi
period
confid
interv
ci
overal
rate
viral
infect
grade
case
compar
grade
higher
thu
patient
lower
acut
reject
grade
twice
like
posit
viral
infect
higher
reject
grade
ci
repeat
analys
presenc
viru
upper
respiratori
tract
predictor
acut
reject
find
associ
upper
respiratori
tract
viral
infect
acut
reject
ci
supplementari
analysi
verifi
occurr
acut
reject
period
baselin
bronchoscopi
day
probabl
acut
reject
associ
presenc
acut
reject
baselin
use
extens
panel
molecular
assay
abl
show
prospect
collect
bal
fluid
specimen
adult
lung
transplant
recipi
posit
least
respiratori
viru
basi
pretest
clinic
evalu
patient
test
posit
significantli
like
present
respiratori
symptom
compar
identifi
viru
analyz
individu
symptom
systemat
frequent
presenc
respiratori
viru
particularli
cough
sputum
time
common
consist
observ
pretest
clinic
evalu
perform
physician
charg
consid
infect
like
final
posit
viral
detect
furthermor
lung
function
prove
recov
significantli
slower
presenc
respiratori
viru
find
corrobor
posit
associ
exist
posit
viral
nucleic
acid
detect
bal
fluid
presenc
acut
respiratori
ill
lung
transplant
patient
also
concord
investig
link
detect
respiratori
virus
rtpcr
symptom
howev
investig
differ
studi
prospect
design
larg
panel
respiratori
virus
screen
systemat
use
bal
specimen
integr
pretest
clinic
evalu
perform
physician
charg
mani
previou
studi
limit
detect
strategi
upper
respiratori
tract
specimen
use
array
molecular
tool
often
restrict
subgroup
virus
eg
rhinovirus
coronavirus
bocavirus
systemat
test
final
link
pretest
clinic
condit
detail
mani
report
avail
lung
biopsi
specimen
case
also
abl
assess
presenc
acut
reject
accord
presenc
viral
infect
relationship
acut
viral
infect
subsequ
acut
reject
report
small
case
seri
possibl
associ
appropri
confirm
viral
infect
might
trigger
chain
immunolog
mediat
event
lead
subsequ
reject
lung
dysfunct
import
sever
studi
identifi
viral
infect
distinct
risk
factor
develop
bronchiol
obliteran
syndrom
chronic
graft
dysfunct
investig
capac
address
question
abl
analyz
high
number
lung
biopsi
specimen
togeth
viral
screen
level
lower
respiratori
tract
biopsi
analysi
reveal
viral
respiratori
tract
infect
associ
simultan
acut
reject
furthermor
could
show
probabl
acut
reject
increas
day
lower
airway
respiratori
viral
infect
present
howev
viral
infect
caus
sever
lung
dysfunct
significantli
hamper
shortterm
function
recoveri
case
concomit
acut
reject
clinician
charg
mask
viral
result
posit
rtpcr
result
modifi
treatment
simultan
acut
reject
thu
less
aggress
treatment
acut
reject
presenc
viru
explain
slower
recoveri
lung
function
patient
suggest
respiratori
virus
per
se
promot
acut
reject
acut
phase
could
certainli
worsen
lung
function
impair
recoveri
acut
reject
episod
paradox
even
observ
neg
associ
episod
respiratori
viral
infect
subsequ
cumul
risk
develop
acut
reject
consid
protect
effect
viral
infect
like
lack
associ
chanc
effect
refrain
draw
conclus
howev
strongli
suggest
analyz
biopsi
specimen
accord
refer
guidelin
pathologist
misguid
presenc
viral
infect
note
studi
design
limit
followup
week
exclud
possibl
viral
infect
trigger
chain
immunolog
mediat
event
lead
subsequ
reject
lung
dysfunct
import
sever
studi
identifi
viral
infect
distinct
risk
factor
develop
bronchiol
obliteran
syndrom
chronic
graft
dysfunct
investig
also
provid
uniqu
opportun
compar
viral
detect
upper
pool
nasopharyng
oropharyng
swab
lower
respiratori
tract
larg
number
pair
specimen
posit
rate
upper
respiratori
tract
compar
lower
tract
differ
recoveri
rate
similar
observ
smaller
studi
best
knowledg
none
previou
investig
systemat
analyz
pair
specimen
collect
procedur
import
observ
recov
upper
respiratori
tract
respiratori
virus
less
like
associ
lower
respiratori
symptom
anoth
interest
observ
neg
nasopharyng
specimen
associ
discord
posit
bal
viral
screen
thu
suggest
high
neg
predict
valu
howev
valu
balanc
rel
low
preval
individu
respiratori
viru
bal
fluid
specimen
possibl
technic
issu
relat
nasopharyng
pharyng
swab
could
neg
affect
recoveri
rate
popul
first
select
basi
need
perform
bal
procedur
reason
caution
lower
respiratori
tract
viral
infect
lung
transplant
recipi
definit
rule
nasopharyng
swab
yet
could
reason
initi
screen
strategi
need
confirm
studi
individu
type
viru
conclus
studi
demonstr
tempor
relationship
lung
transplant
recipi
emerg
acut
respiratori
symptom
posit
respiratori
viral
nucleic
acid
detect
bal
fluid
specimen
detect
upper
respiratori
tract
viral
infect
less
like
associ
respiratori
symptom
graft
dysfunct
also
provid
solid
evid
suggest
respiratori
virus
per
se
promot
acut
graft
reject
least
acut
phase
infect
worsen
graft
function
recoveri
simultan
present
acut
reject
